{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:09:17Z","timestamp":1790629757399,"version":"4.1.0"},"reference-count":51,"publisher":"Wiley","issue":"15","license":[{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Cellular Molecular Medi"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Breast cancer has a diverse aetiology characterized by the heterogeneous expression of hormone receptors and signalling molecules, resulting in varied sensitivity to chemotherapy. The adverse side effects of chemotherapy coupled with the development of drug resistance have prompted the exploration of natural products to combat cancer. Lactoferricin B (LfcinB) is a natural peptide derived from bovine lactoferrin that exhibits anticancer properties. LfcinB was evaluated in vitro for its inhibitory effects on cell lines representing different categories of breast cancer and in vivo for its suppressive effects on tumour xenografts in NOD\u2010SCID mice. The different breast cancer cell lines exhibited varied levels of sensitivity to apoptosis induced by LfcinB in the order of SKBR3&gt;MDA\u2010MB\u2010231&gt;MDA\u2010MB\u2010468&gt;MCF7, while the normal breast epithelial cells MCF\u201010A were not sensitive to LfcinB. The peptide also inhibited the invasion of the MDA\u2010MB\u2010231 and MDA\u2010MB\u2010468 cell lines. In the mouse xenograft model, intratumoural injections of LfcinB significantly reduced tumour growth rate and tumour size, as depicted by live imaging of the mice using in vivo imaging systems (IVIS). Harvested tumour volume and weight were significantly reduced by LfcinB treatment. LfcinB, therefore, is a promising and safe candidate that can be considered for the treatment of breast cancer.<\/jats:p>","DOI":"10.1111\/jcmm.16748","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T10:49:27Z","timestamp":1625741367000},"page":"7181-7189","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Inhibition of breast cancer xenografts in a mouse model and the induction of apoptosis in multiple breast cancer cell lines by lactoferricin B peptide"],"prefix":"10.1111","volume":"25","author":[{"given":"Rizdwan","family":"Rahman","sequence":"first","affiliation":[{"name":"School of Post Graduate Studies International Medical University Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa Danielle","family":"Fonseka","sequence":"additional","affiliation":[{"name":"School of Health Sciences International Medical University Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiang\u2010Chia","family":"Sua","sequence":"additional","affiliation":[{"name":"School of Medicine International Medical University Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munirah","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Molecular Pathology Unit Cancer Research Centre Institute for Medical Research National Institutes of Health Ministry of Health Malaysia Shah Alam, Selangor Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3610-8430","authenticated-orcid":false,"given":"Ramkumar","family":"Rajendran","sequence":"additional","affiliation":[{"name":"School of Pharmacy International Medical University Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Ambu","sequence":"additional","affiliation":[{"name":"School of Post Graduate Studies International Medical University Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7297-5948","authenticated-orcid":false,"given":"Fabian","family":"Davamani","sequence":"additional","affiliation":[{"name":"School of Health Sciences International Medical University Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8268-5271","authenticated-orcid":false,"given":"Alan Soo\u2010Beng","family":"Khoo","sequence":"additional","affiliation":[{"name":"School of Post Graduate Studies International Medical University Kuala Lumpur Malaysia"},{"name":"Molecular Pathology Unit Cancer Research Centre Institute for Medical Research National Institutes of Health Ministry of Health Malaysia Shah Alam, Selangor Malaysia"},{"name":"Institute for Research Development and Innovation International Medical University Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5818-6587","authenticated-orcid":false,"given":"Ebenezer","family":"Chitra","sequence":"additional","affiliation":[{"name":"School of Health Sciences International Medical University Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.10.10.13879"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2018.03.006"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.1870"},{"key":"e_1_2_9_6_1","article-title":"Triple negative breast cancer: 10\u2010year survival update of the applied treatment strategy in kuwait","author":"Fayaz S","year":"2019","journal-title":"Gulf J Oncolog"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/1179554918790563"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2018.01.002"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom10030456"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00002"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/390230"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2013.07.006"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7199"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.3168\/jds.2013-7285"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21886"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2010.02.001"},{"issue":"5","key":"e_1_2_9_17_1","first-page":"1385","article-title":"Lactoferricin\u2010induced apoptosis in estrogen\u2010nonresponsive MDA\u2010MB\u2010435 breast cancer cells is enhanced by C6 ceramide or tamoxifen","volume":"15","author":"Furlong SJ","year":"2006","journal-title":"Oncol Rep"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.08.083"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1139\/bcb-2016-0175"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.12.043"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-005-3557-3"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1139\/o01-213"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060462"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2889"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.3233\/BD-2010-0307"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04301-8"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204342"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000543"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/630179"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/psc.1039"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22101641"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1039\/C9RA04145A"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-04-0077"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-5370-2"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2013.200"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/nure.12155"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4644(19990901)74:3<486::AID-JCB16>3.0.CO;2-6"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2014.956260"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/psc.2670"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FPJ04047X"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24151"},{"key":"e_1_2_9_42_1","article-title":"Effects of adenovirus vectors mediated human lactoferrin cDNA on mice bearing EMT6 breast carcinoma","author":"Wang J","year":"2011","journal-title":"Pharmazie"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2010.0937"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-011-0616-z"},{"issue":"5","key":"e_1_2_9_45_1","first-page":"2703","article-title":"Evidence for a direct antitumor mechanism of action of bovine lactoferricin","volume":"22","author":"Tone Eliassen L","year":"2002","journal-title":"Anticancer Res"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2015.04.006"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1997.tb00364.x"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-010-0857-6"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-018-1092-x"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2017-0088"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2007.05.015"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-010-9341-1"}],"container-title":["Journal of Cellular and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcmm.16748","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jcmm.16748","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcmm.16748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T08:02:44Z","timestamp":1693296164000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcmm.16748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":51,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1111\/jcmm.16748"],"URL":"https:\/\/doi.org\/10.1111\/jcmm.16748","archive":["Portico"],"relation":{},"ISSN":["1582-1838","1582-4934"],"issn-type":[{"value":"1582-1838","type":"print"},{"value":"1582-4934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,8]]},"assertion":[{"value":"2021-02-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}